Cathie Wood's Latest Moves: 3 Stocks She Invested In Recently
Cathie Wood, the renowned investor and co-founder of Ark Invest, has made headlines again with her recent stock purchases. On Tuesday, Wood added to her stakes in Advanced Micro Devices (AMD), Shopify, and Intellia Therapeutics. These moves come as Wood’s investing strategy is gaining traction, with her most popular ETF rising 6% over the past month. Let’s dive into the details of her latest investments and what they mean for investors.
Advanced Micro Devices (AMD)
AMD is set to report its first-quarter results next week, and analysts are expecting a strong performance. Revenue is projected to rise by 30% to $7.1 billion, marking AMD’s strongest year-over-year growth in nearly three years. Earnings are also expected to jump by 52% to $0.94 per share, a record for the company. Despite these positive expectations, AMD’s shares have dropped by 40% over the past year, making it an attractive option for Wood. The company’s growth is driven by the increasing demand for AI chips and data center buildouts, though it faces challenges such as a $800 million charge related to the banning of its MI308X processor in China.
Shopify
Shopify, the popular e-commerce platform, is also set to report its latest results shortly after AMD. Analysts predict a 25% to 30% increase in both revenue and earnings, continuing a streak of strong growth that has lasted over a decade. Despite these expectations, Shopify’s shares have faced downward pressure as analysts have reduced their price targets, citing concerns about consumer confidence and retail trends. However, the company’s long-term prospects remain bright, with Shopify facilitating over $1 trillion in transactions since 2006, half of which occurred in the past two years.
Intellia Therapeutics
Intellia Therapeutics, a developer of CRISPR-based therapies, has caught Wood’s attention amid a recent upgrade from Wolfe Research. The stock now carries an ‘Outperform’ rating, driven by its strong net-cash position and compelling enterprise value. With a market cap nearing $850 million, Intellia’s enterprise value is below $200 million, making it an attractive investment. Analysts predict significant upside, with a price target suggesting the stock could more than double from its current price.
Conclusion
Cathie Wood’s recent investments in AMD, Shopify, and Intellia Therapeutics highlight her focus on undervalued companies with strong growth potential. While each of these stocks faces its own challenges, their fundamentals and market positions suggest that they could be poised for success. As Wood’s track record continues to impress, investors may want to consider whether these stocks have a place in their portfolios. With the market environment remaining uncertain, now is the time to evaluate opportunities and make informed decisions.返回搜狐，查看更多
平台声明：该文观点仅代表作者本人，搜狐号系信息发布平台，搜狐仅提供信息存储空间服务。